发明名称 Medicaments for tumour therapy - contg. trace elements, glycine, glycerol, ascorbic acid, tetra:halo-fluorescein, EDTA and tartrate
摘要 <p>Aq. pharmaceutical compsns., esp. for tumour therapy, comprise (a) a mixt. of water soluble B, F, Mg, V, Mn, Fe, Co, Ni, Cu, Zn and Mo cpds. which do not ppte. with one another or with the other components of the compsn. and which provide an acid or neutral pH; (b) glycine; (c) glycerol; (d) ascorbic acid; (e) a water-soluble neutral or acid salt of a 2,4,5,7-tetrahalofluorescein; (f) a water-soluble neutral or acid salt of ethylenediaminetetracetic acid (EDTA); and (g) Na and K double tatrate. These components are formulated with H2O and opt. other carriers, diluents and/or additives. The compsns. can be used for treatment or prophylaxis of a wide range of malignant tumours. They have no harmful side-effects and, as well as causing tumour regression, they have favourable effects and, as well as causing tumour regression, they have favourable effects on nausea, osteoporosis, pain, fatigue, insomnia, anaemia, hair loss and other symptoms.</p>
申请公布号 DE2827478(A1) 申请公布日期 1980.01.17
申请号 DE19782827478 申请日期 1978.06.22
申请人 BERES,JOZSEF,DR. 发明人 BERES,JOZSEF,DR.
分类号 A61K9/02;A61K33/34;(IPC1-7):61K33/00;61K31/045;61K31/19;61K31/195;61K31/35;61K31/375 主分类号 A61K9/02
代理机构 代理人
主权项
地址